Prevalence and Responsiveness to Treatment of Lung Abnormalities on Chest Computed Tomography in Patients with Microscopic Polyangiitis: A Multicenter, Longitudinal, Retrospective Study of One Hundred Fifty Consecutive Hospital-Based Japanese Patients

Arthritis and Rheumatology

Volumn 68, Issue 3, 2016, Pages 713-723

  Yamagata, Mieko ^a   Ikeda, Kei ^a   Tsushima, Kenji ^a   Iesato, Ken ^a   Abe, Mitsuhiro ^a   Ito, Takashi ^a,b   Kashiwakuma, Daisuke ^b   Kagami, Shin Ichiro ^b   Iwamoto, Itsuo ^b   Nakagomi, Daiki ^c   Sugiyama, Takao ^c   Maruyama, Yuichiro ^d   Furuta, Shunsuke ^a,e   Jayne, David ^e   Uno, Takashi ^a   Tatsumi, Koichiro ^a   Nakajima, Hiroshi ^a  

^a CHIBA UNIVERSITY   (Japan)

^b ASAHI GENERAL HOSPITAL   (Japan)

^c SHIMOSHIZU HOSPITAL   (Japan)

^d Komoro Kousei General Hospital   (Japan)

^e ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN; METHYLPREDNISOLONE; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISOLONE; IMMUNOSUPPRESSIVE AGENT; PEROXIDASE;

ADULT; AGED; ARTICLE; BIRMINGHAM VASCULITIS ACTIVITY SCORE; BRONCHIOLITIS; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FIBROSING ALVEOLITIS; HUMAN; INTERSTITIAL LUNG DISEASE; JAPAN; LUNG EMPHYSEMA; MAJOR CLINICAL STUDY; MALE; MICROSCOPIC POLYANGIITIS; MORTALITY; PLEURA DISEASE; PREVALENCE; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; RETROSPECTIVE STUDY; SCORING SYSTEM; SURVIVAL; THORAX SCINTISCANNING; TREATMENT RESPONSE; AIRWAY OBSTRUCTION; CLINICAL TRIAL; COMPLICATION; IMMUNOLOGY; LONGITUDINAL STUDY; LUNG DISEASES; MIDDLE AGED; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; RADIOGRAPHY; THORAX RADIOGRAPHY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; AIRWAY OBSTRUCTION; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; FEMALE; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; IMMUNOSUPPRESSIVE AGENTS; LONGITUDINAL STUDIES; LUNG DISEASES; LUNG DISEASES, INTERSTITIAL; MALE; MICROSCOPIC POLYANGIITIS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PEROXIDASE; PLEURAL DISEASES; PULMONARY EMPHYSEMA; RADIOGRAPHY, THORACIC; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84963877030     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.39475     Document Type: Article

References (43)

1. Mukhtyar C, Flossmann O, Hellmich B, Bacon P, Cid M, Cohen-Tervaert JW, et al., Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force. Ann Rheum Dis 2008; 67: 1004-10.
2. Berden A, Goceroglu A, Jayne D, Luqmani R, Rasmussen N, Bruijn JA, et al., Diagnosis and management of ANCA associated vasculitis. BMJ 2012; 344: e26.
3. Guillevin L, Durand-Gasselin B, Cevallos R, Gayraud M, Lhote F, Callard P, et al., Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients. Arthritis Rheum 1999; 42: 421-30.
4. Hassan TM, Hassan AS, Igoe A, Logan M, Gunaratnam C, McElvaney NG, et al., Lung involvement at presentation predicts disease activity and permanent organ damage at 6, 12 and 24 months follow-up in ANCA-associated vasculitis. BMC Immunol 2014; 15: 20.
5. Furuta S, Chaudhry AN, Hamano Y, Fujimoto S, Nagafuchi H, Makino H, et al., Comparison of phenotype and outcome in microscopic polyangiitis between Europe and Japan. J Rheumatol 2014; 41: 325-33.
6. Gomez-Puerta JA, Hernandez-Rodriguez J, Lopez-Soto A, Bosch X., Antineutrophil cytoplasmic antibody-associated vasculitides and respiratory disease. Chest 2009; 136: 1101-11.
7. Tzelepis GE, Kokosi M, Tzioufas A, Toya SP, Boki KA, Zormpala A, et al., Prevalence and outcome of pulmonary fibrosis in microscopic polyangiitis. Eur Respir J 2010; 36: 116-21.
8. Arulkumaran N, Periselneris N, Gaskin G, Strickland N, Ind PW, Pusey CD, et al., Interstitial lung disease and ANCA-associated vasculitis: a retrospective observational cohort study. Rheumatology (Oxford) 2011; 50: 2035-43.
9. Gaudin PB, Askin FB, Falk RJ, Jennette JC., The pathologic spectrum of pulmonary lesions in patients with anti-neutrophil cytoplasmic autoantibodies specific for anti-proteinase 3 and anti-myeloperoxidase. Am J Clin Pathol 1995; 104: 7-16.
10. Cottin V, Nunes H, Mouthon L, Gamondes D, Lazor R, Hachulla E, et al., Combined pulmonary fibrosis and emphysema syndrome in connective tissue disease. Arthritis Rheum 2011; 63: 295-304.
11. Cottin V, Nunes H, Brillet PY, Delaval P, Devouassoux G, Tillie-Leblond I, et al., Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity. Eur Respir J 2005; 26: 586-93.
12. Tzouvelekis A, Zacharis G, Oikonomou A, Koulelidis A, Steiropoulos P, Froudarakis M, et al., Combined pulmonary fibrosis and emphysema associated with microscopic polyangiitis. Eur Respir J 2012; 40: 505-7.
13. Tzouvelekis A, Zacharis G, Oikonomou A, Mikroulis D, Margaritopoulos G, Koutsopoulos A, et al., Increased incidence of autoimmune markers in patients with combined pulmonary fibrosis and emphysema. BMC Pulm Med 2013; 13: 31.
14. Fujimoto S, Watts RA, Kobayashi S, Suzuki K, Jayne DR, Scott DG, et al., Comparison of the epidemiology of anti-neutrophil cytoplasmic antibody-associated vasculitis between Japan and the U.K. Rheumatology (Oxford) 2011; 50: 1916-20.
15. Lyons PA, Rayner TF, Trivedi S, Holle JU, Watts RA, Jayne DR, et al., Genetically distinct subsets within ANCA-associated vasculitis. N Engl J Med 2012; 367: 214-23.
16. Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, et al., 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 2013; 65: 1-11.
17. Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, et al., Nomenclature of systemic vasculitides: proposal of an international consensus conference. Arthritis Rheum 1994; 37: 187-92.
18. De Groot K, Gross WL, Herlyn K, Reinhold-Keller E., Development and validation of a disease extent index for Wegener's granulomatosis. Clin Nephrol 2001; 55: 31-8.
19. Luqmani RA, Bacon PA, Moots RJ, Janssen BA, Pall A, Emery P, et al., Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. QJM 1994; 87: 671-8.
20. Mukhtyar C, Lee R, Brown D, Carruthers D, Dasgupta B, Dubey S, et al., Modification and validation of the Birmingham Vasculitis Activity Score (version 3). Ann Rheum Dis 2009; 68: 1827-32.
21. Hansell DM, Bankier AA, MacMahon H, McLoud TC, Muller NL, Remy J., Fleischner Society: glossary of terms for thoracic imaging. Radiology 2008; 246: 697-722.
22. Sumikawa H, Johkoh T, Colby TV, Ichikado K, Suga M, Taniguchi H, et al., Computed tomography findings in pathological usual interstitial pneumonia: relationship to survival. Am J Respir Crit Care Med 2008; 177: 433-9.
23. Travis WD, Costabel U, Hansell DM, King TE Jr, Lynch DA, Nicholson AG, et al., An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2013; 188: 733-48.
24. Lanza ST, Collins LM, Lemmon DR, Schafer JL., PROC LCA: A SAS procedure for latent class analysis. Struct Equ Modeling 2007; 14: 671-94.
25. Grayson PC, Maksimowicz-McKinnon K, Clark TM, Tomasson G, Cuthbertson D, Carette S, et al., Distribution of arterial lesions in Takayasu's arteritis and giant cell arteritis. Ann Rheum Dis 2012; 71: 1329-34.
26. Lanza S, Dziak J, Huang L, Wagner A, Collins L., PROC LCA & PROC LTA users' guide (version 1.3.0). University Park: The Methodology Center, Penn State; 2013.
27. Sada KE, Yamamura M, Harigai M, Fujii T, Dobashi H, Takasaki Y, et al., Classification and characteristics of Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis in a nationwide, prospective, inception cohort study. Arthritis Res Ther 2014; 16: R101.
28. Foulon G, Delaval P, Valeyre D, Wallaert B, Debray MP, Brauner M, et al., ANCA-associated lung fibrosis: analysis of 17 patients. Respir Med 2008; 102: 1392-8.
29. Hervier B, Pagnoux C, Agard C, Haroche J, Amoura Z, Guillevin L, et al., Pulmonary fibrosis associated with ANCA-positive vasculitides. Retrospective study of 12 cases and review of the literature. Ann Rheum Dis 2009; 68: 404-7.
30. Yamada H., ANCA: associated lung fibrosis. Semin Respir Crit Care Med 2011; 32: 322-7.
31. Homma S, Matsushita H, Nakata K., Pulmonary fibrosis in myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitides. Respirology 2004; 9: 190-6.
32. Cottin V, Cordier JF., Combined pulmonary fibrosis and emphysema in connective tissue disease. Curr Opin Pulm Med 2012; 18: 418-27.
33. Ohno S, Nakaya T, Bando M, Sugiyama Y., Idiopathic pulmonary fibrosis: results from a Japanese nationwide epidemiological survey using individual clinical records. Respirology 2008; 13: 926-8.
34. Natsuizaka M, Chiba H, Kuronuma K, Otsuka M, Kudo K, Mori M, et al., Epidemiologic survey of Japanese patients with idiopathic pulmonary fibrosis and investigation of ethnic differences. Am J Respir Crit Care Med 2014; 190: 773-9.
35. Takahashi K, Hayashi S, Ushiyama O, Sueoka N, Fukuoka M, Nagasawa K., Development of microscopic polyangiitis in patients with chronic airway disease. Lung 2005; 183: 273-81.
36. Sitara D, Hoffbrand BI., Chronic bronchial suppuration and antineutrophil cytoplasmic antibody (ANCA) positive systemic vasculitis. Postgrad Med J 1990; 66: 669-71.
37. Matsuyama W, Wakimoto J, Watanabe A, Kubota I, Hirotsu Y, Mizoguchi A, et al., Bronchiectasis with myeloperoxidase antineutrophil cytoplasmic antibody and bactericidal/permeability-increasing protein antineutrophil cytoplasmic antibody. Intern Med 1999; 38: 813-6.
38. Nagata T, Hara K, Oka T, Yamaguchi Y, Igarashi K, Hazama H, et al., Microscopic polyangiitis associated with sinobronchial syndrome. Intern Med 2001; 40: 544-7.
39. Schnabel A, Reuter M, Csernok E, Richter C, Gross WL., Subclinical alveolar bleeding in pulmonary vasculitides: correlation with indices of disease activity. Eur Respir J 1999; 14: 118-24.
40. Birnbaum J, Danoff S, Askin FB, Stone JH., Microscopic polyangiitis presenting as a "pulmonary-muscle" syndrome: is subclinical alveolar hemorrhage the mechanism of pulmonary fibrosis? Arthritis Rheum 2007; 56: 2065-71.
41. Foucher P, Heeringa P, Petersen AH, Huitema MG, Brouwer E, Tervaert JW, et al., Antimyeloperoxidase-associated lung disease. An experimental model. Am J Respir Crit Care Med 1999; 160: 987-94.
42. Lucattelli M, Bartalesi B, Cavarra E, Fineschi S, Lunghi B, Martorana PA, et al., Is neutrophil elastase the missing link between emphysema and fibrosis? Evidence from two mouse models. Respir Res 2005; 6: 83.
43. Gehrig S, Duerr J, Weitnauer M, Wagner CJ, Graeber SY, Schatterny J, et al., Lack of neutrophil elastase reduces inflammation, mucus hypersecretion, and emphysema, but not mucus obstruction, in mice with cystic fibrosis-like lung disease. Am J Respir Crit Care Med 2014; 189: 1082-92.